Maged Shenouda - 26 Jun 2025 Form 4 Insider Report for RELMADA THERAPEUTICS, INC. (RLMD)

Signature
/s/ Maged Shenouda
Issuer symbol
RLMD
Transactions as of
26 Jun 2025
Net transactions value
$0
Form type
4
Filing time
30 Jun 2025, 19:29:01 UTC
Previous filing
20 May 2025
Next filing
06 Nov 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Shenouda Maged Chief Financial Officer C/O RELMADA THERAPEUTICS, INC., 2222 PONCE DE LEON BLVD, 3RD FLOOR, CORAL GABLES, /s/ Maged Shenouda 30 Jun 2025 0001658369

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RLMD Stock Option (right to buy) Award $0 +600,000 $0.000000 600,000 26 Jun 2025 Common Stock 600,000 $0.6700 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest in 16 equal quarterly installments commencing on September 26, 2025.